Beacon Pharmaceuticals PLC

DSE:BEACONPHAR Stock Report

Market Cap: ৳31.4b

Beacon Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Mohammad Karim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership25.2%
Management average tenure1.3yrs
Board average tenure1.3yrs

Recent management updates

Recent updates

CEO

Mohammad Karim (68 yo)

no data

Tenure

৳780,000

Compensation

Mr. Mohammad Ebadul Karim serves as Managing Director and Director at Beacon Pharmaceuticals Limited.

Leadership Team

NamePositionTenureCompensationOwnership
Mohammad Karim
MD & Directorno data৳780.00k25.21%
BDT 7.9b
Md. Uddin
CFO & Head of IT1.6yrsno datano data
Ulfat Karim
COO & Director1.3yrsno data9.86%
BDT 3.1b
Md. Alam
Director of HRno datano datano data
Mohammad Anisur Khan
Executive Vice President of Estate & Public Relationsno datano datano data
S. M. Hoque
Executive Vice President of Marketing & Salesno datano datano data
Monjurul Alam
Chief Executive Officer of Global Business Developmentno datano datano data
Rahamat Huda
Head of Internal Audit & VPno datano datano data
Shams Monzur
Executive Vice President of Project Managementno datano datano data
Sharif Al Mahmud
Head of Enterprise Systemsno datano datano data
Md. Shahabuddin
Company Secretaryless than a yearno datano data

1.3yrs

Average Tenure

Experienced Management: BEACONPHAR's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Mohammad Karim
MD & Directorno data৳780.00k25.21%
BDT 7.9b
Ulfat Karim
COO & Director1.3yrsno data9.86%
BDT 3.1b
Mohammad Karim
Director18yrsno data2.75%
BDT 863.5m
Nurun Karim
Chairmanno datano data2.05%
BDT 642.1m
Rezanur Chowdhury
Independent Directorno datano datano data
ABM Faroque
Independent Directorless than a yearno datano data

1.3yrs

Average Tenure

65yo

Average Age

Experienced Board: BEACONPHAR's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 10:04
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beacon Pharmaceuticals PLC is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution